GH:NASDAQ
Guardant Health Inc
$167.47
arrow_upward
+1.15%(+1.91) 1D
$167.40
arrow_downward
-0.04% (-0.070)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$166.03
High
$170.81
Low
$166.03
Mkt. cap
22.47B
Avg. vol.
1.87M
Volume
1.52M
52-wk high
$191.01
52-wk low
$61.00
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
Open
$166.03
High
$170.81
Low
$166.03
Mkt. cap
22.47B
Avg. vol.
1.87M
Volume
1.52M
52-wk high
$191.01
52-wk low
$61.00
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
News stories
From web sources and news partners
Insider Monkey
·
1 day ago
Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy?
Investing.com Australia
·
2 days ago
Guardant Health receives European approval for breast cancer test By Investing.com
Stock Titan
·
2 days ago
A blood test in Europe can help identify who may benefit from AstraZeneca’s breast cancer drug
Yahoo Finance
·
2 days ago
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth care provider
Websiteguardanthealth.com